BioCentury
ARTICLE | Management Tracks

Pioneering geneticist Altshuler retiring from Vertex

A founding core member of the Broad Institute, David Altshuler will step aside next year

August 7, 2025 10:24 PM UTC

EVP and CSO David Altshuler will retire from Vertex on Aug. 1, 2026, after more than a decade with the company that resulted in several high-profile approvals. He leads internal research and external innovation, corporate data strategy, technology and data sciences.

SVP of Global Research Mark Bunnage will take over as CSO effective Feb. 1, 2026. ...

BCIQ Company Profiles

Vertex Pharmaceuticals Inc.